Skip to Content

C170 (Darifenacin hydrobromide extended-release 7.5 mg (base))

This pill with imprint "C170" is Yellow, Round and has been identified as Darifenacin hydrobromide extended-release 7.5 mg (base). It is manufactured by Par Pharmaceutical, Inc..

Darifenacin is used in the treatment of urinary incontinence; overactive bladder and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Darifenacin hydrobromide extended-release 7.5 mg (base) C170
Discount Card Promo
Darifenacin hydrobromide extended-release
Imprint:
C170
Strength:
7.5 mg (base)
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Par Pharmaceutical, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide